Abbott Laboratories (ABT)

Cash & Short-Term Investments

$5.60B

Quarterly · Period ending: · USD

ABT logo

ABT Cash & Short-Term Investments

Latest reported$5.60B
ABT Quarterly Cash & Short-Term Investments ($437.50M → $5.60B)
High-resolution chart · PNG

ABT cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
884,823,000
758,190,000
1,156,718,000
967,641,000
984,251,000
775,347,000
723,296,000
630,380,000
401,750,000
396,813,000
383,317,000
274,033,000
323,009,000
294,945,000
259,010,000
165,584,000
145,190,000
152,231,000
123,084,000
179,170,000
177,671,000
131,957,000
315,697,000
414,671,000
310,858,000
250,052,000
315,328,000
318,687,000
249,073,000
207,606,000
378,825,000
137,800,000
29,500,000
51,500,000
116,600,000
27,200,000
38,400,000
22,500,000
60,400,000
49,500,000
57,700,000
54,300,000
34,000,000
117,500,000
36,100,000
76,600,000
13,600,000
582,600,000
519,900,000
481,600,000
437,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.